12 hasil untuk "Banerjee, Subho"
Menampilkan 1–12 · 0,43 detik · RSS
-
Artikel Jurnal Teks lengkap
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
BACKGROUND: We aimed to analyze the humoral and cellular response to standard and booster (additional doses) COVID‐19 vaccination in solid organ transplantation (SOT) and the risk factors involved for an impaired response. METHODS: We did a systematic review and meta‐analysis of studies published…
-
Artikel Jurnal Teks lengkap
Dialysis Vascular Access: Where do Tunneled Catheters Stand? – A Single-Center Experience
INTRODUCTION: Tunneled cuffed catheters (TCC) provides a short and intermediate-term access solution for dialysis patients who fail to get an arteriovenous fistula (AVF). They are associated with high morbidity and mortality along with high rates of infectious complications. METHODS: We present a…
-
Artikel Jurnal Teks lengkap
COVID-19 in Hemodialysis Patients: Experience from a Western Indian Center
INTRODUCTION: Chronic kidney disease patients on hemodialysis (CKD-5D) are among the worst hit by the coronavirus disease 2019 (COVID-19) pandemic. Need to travel for dialysis, comorbidities, and immunosuppressive state put them at risk of severe disease and poor outcomes. We report our experience…
-
Artikel Jurnal Teks lengkap
Feasibility and safety of remdesivir in SARS‐CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation
INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV2) infection has drastically impacted the transplant communities. Remdesivir (RDV) has shown some promising results in coronavirus disease (COVID‐19) albeit with low certainty. Data in kidney transplant recipients (KTR) are…
-
Artikel Jurnal Teks lengkap
Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India
PURPOSE: Coronavirus disease (COVID-19) sequelae in the transplant population are scarcely reported. Post-COVID-19 mucormycosis is one of such sequelae, which is a dreadful and rare entity. The purpose of this report was to study the full spectrum of this dual infection in kidney transplant…
-
Artikel Jurnal Teks lengkap
COVID-19 in Kidney Transplant Recipients Vaccinated With Oxford–AstraZeneca COVID-19 Vaccine (Covishield): A Single-center Experience From India
[Image: see text]
-
Artikel Jurnal Teks lengkap
Fatal outcome subsequent to reoccurring SARS‐CoV2 infection in a kidney transplant recipient
-
Artikel Jurnal Teks lengkap
Consequences of the first and second COVID‐19 wave on kidney transplant recipients at a large Indian transplant centre
BACKGROUND: There is a scarcity of data comparing the consequences of first and second COVID‐19 waves on kidney transplant recipients (KTRs) in India. METHODS: We conducted a single‐centre retrospective study of 259 KTRs with COVID‐19 to compare first wave (March 15–December 31 2020, n = 157) and…
-
Artikel Jurnal Teks lengkap
Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation
Kidney transplantation (KT) accounts for nearly three-fourths of organ transplants in India, with living donors contributing to 82% of cases. Induction immunosuppression is essential to optimize initial immunosuppression, reduce acute rejections, and enable tailored use of maintenance agents…
-
Artikel Jurnal Teks lengkap
ISOT position statement on the feasibility of an organ for transplantation from brain-dead deceased donors: a Delphi consensus
Organ shortage remains a critical challenge in India’s transplant landscape, despite established deceased donor organ transplantation (DDOT) programmes. Many potentially viable organs from brain-dead deceased donors (DBDs) are discarded due to uncertainties surrounding donor suitability in specific…
-
Artikel Jurnal Teks lengkap
Analysis of kidney and liver exchange transplantation in India (2000–2025): a multicentre, retrospective cohort study
BACKGROUND: In India, where deceased organ donation rates are relatively low, living donor transplantation programmes face challenges due to ABO incompatibility and sensitisation. Approximately one-third of healthy, willing living donors are incompatible with their intended recipients due to these…